FDA Conditionally Approves First Drug to Delay Onset of Congestive Heart Failure in Dogs
Today the U.S. Food and Drug Administration conditionally approved Vetmedin-CA1 (pimobendan) chewable tablets, the first drug indicated for delaying the onset of congestive heart failure in dogs with Stage B2 preclinical myxomatous mitral valve disease (MMVD). MMVD is a condition in dogs where an abnormal heart valve allows blood to leak backward (regurgitation), impacting the […]
FDA Conditionally Approves First Drug to Delay Onset of Congestive Heart Failure in Dogs Read More »